Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Axiom PangenomiX Array

Thermo Fisher Scientific has launched the Axiom PangenomiX Array for population-scale disease and pharmacogenomics research. The array combines SNP genotyping, whole-genome copy number variant detection, fixed copy number discovery, as well as blood and HLA typing. It is designed for disease risk and detection research, ancestry and wellness testing, drug efficacy testing, and drug development research. The array includes clinically relevant PGx markers and pathogenic variants and offers enhanced whole-genome imputation as well as a high level of diversity for testing different ethnicities.